Cannabis Report
Lithium
Home > Boards > US OTC > Biotechs >

Oncolix Inc. (ONCX)

ONCX RSS Feed
Add ONCX Price Alert      Hide Sticky   Hide Intro
Moderator: reaper247, BeeDoubleU, Rat Fink, namtae, AltJactUp, steadyhand
Search This Board: 
Last Post: 8/22/2018 1:15:13 AM - Followers: 159 - Board type: Free - Posts Today: 1



A pharmaceutical company in Harris County, Texas.
OTCQB: ONCX

14405 Walters Rd, Houston, TX 77014
(281) 402-3168
Contact Us
\

Oncolix, Inc. (Oncolix) is a clinical-stage biotechnology company

We are developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers. The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in our first indication, the treatment of ovarian cancer.  This clinical trial began in 2016. Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat. Prolanta™ is a prolactin receptor antagonist that has demonstrated significant efficacy in xenograft models through a unique mechanism of action, autophagy (see Our Science). In addition to ovarian cancer, there is strong preclinical evidence Prolanta™ will be effective in breast, prostate and other cancers.

The FDA has also approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer, which may allow reduced filing fees, federal tax credits and marketing exclusivity by the FDA.

Proudly partnered with Greenville Health System

Oncolix, Inc. (Oncolix) is a bio-pharmaceutical company originally established at the Greenville Health System through the innovative efforts of the Oncology Research Institute in conjunction with the GHS Cancer Center drug discovery program. Oncolix, now based in Houston, Texas, is currently focusing on phase one clinical trials of Prolanta™ - a targeted therapeutic protein for the treatment of breast and ovarian cancer. Prolanta™ was pioneered within the Oncology Research Institute (now known as the Clemson Biomedical Institute) at GHS in Greenville, SC.


Proudly partnered with MD Anderson Cancer Treatment Center


MD Anderson has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report’s “Best Hospitals” survey.

 

Oncolix patents

Oncolix has 30 patents in their patent portfolio, including 8 U.S patents.

\

 
ONCX Security Details
Share Structure
  Market Value1 $5,801,028 a/o Dec 01, 2017
Authorized Shares 950,000,000 a/o Dec 01, 2017
Outstanding Shares 103,877,936 a/o Dec 01, 2017
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 33,311,633 a/o Apr 06, 2017
  Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 101 a/o Apr 06, 2017

As per OTC markets. Updates are pending


Who is Oncolix, Inc.?

https://oncolixbio.com

April 2017 Company Presentation:
https://nebula.wsimg.com/8b544fcbb6f5bf5fb52c1c7e5a69eb81?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1

 

Early funding for Prolactin research was granted from the Susan G. Komen foundation and the U.S government.
More recent funding came from accredited investment including TEXAS TREASURY SAFEKEEPING TRUST CO and the Ernest Mario Family Trust.
Ernest Mario is an American pharmaceutical industry executive and the recipient of the 2007 Remington Honor Medal awarded by the American Pharmacists Association.

 

\

Ernest Mario is the former CEO of GlaxoSmithKilne NYSE: GSK.

He is also Rutgers University alumni who has had the Rutgers School of Pharmacy named after him.


Potential revenue moving forward.

 

 

The Oncolix Team

Management

\

\

Board Members

\

\

\

Prolanta Inventor

\

Company Advisors

\

\



 




 


This space reserved for updates.

 



https://www.otcm
arkets.com/edgar/GetFilingHtml?FilingID=12149068

Cannabis Report
Lithium
ONCX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
#18243   LOL, laraz… reaper247 08/19/18 02:55:12 AM
#18240   LOL, namtae…nonsense. reaper247 08/19/18 12:19:17 AM
PostSubject
#18244  Sticky Note The massive dilution coming up is frightening. namtae 08/19/18 09:23:12 AM
#18240  Sticky Note LOL, namtae…nonsense. reaper247 08/19/18 12:19:17 AM
#18064  Sticky Note ONCX JULY 2018 "BREAKTHROUGH TECHNOLOGY_FOR_WOMEN'S_CANCERS"_PRESENTATION Rat Fink 07/16/18 01:11:22 AM
#17849  Sticky Note Oncolix OTC: ONCX is a pharmaceutical company that reaper247 06/07/18 12:10:14 AM
#18259   Well, garsh namtae. Thanks. reaper247 08/22/18 01:15:13 AM
#18258   ONCX will need more $$ soon, very soon namtae 08/21/18 08:18:00 AM
#18257   LOL, namtae… reaper247 08/21/18 01:17:25 AM
#18256   ONCX JULY 2018 "BREAKTHROUGH TECHNOLOGY_FOR_WOMEN'S_CANCERS"_PRESENTATION Rat Fink 08/20/18 10:09:34 PM
#18255   Good news is on the horizon. AltJactUp 08/20/18 02:28:56 PM
#18253   What was the breakdown of the 63k spent, laraz5 08/20/18 11:20:47 AM
#18252   Only $63k spent last Q with clinicals allegedly namtae 08/20/18 09:52:19 AM
#18251   According to SEC filings, ONCX worth less than ZERO namtae 08/20/18 09:50:48 AM
#18250   Its been 934 days since Prolanta has been laraz5 08/20/18 09:48:37 AM
#18249   BIOPHARMA ONCX/ONCOLIX HAS "8" U.S. PATENTS_&_MANY_FOREIGN_PATENTS! Rat Fink 08/20/18 09:47:00 AM
#18248   6/26/18 PR: "ONCX" APPOINTS WALL STREET_VETERAN_TO_ITS_BOARD_OF_DIRECTORS! Rat Fink 08/20/18 09:46:23 AM
#18247   Total stockholders equity ($6,365,798) namtae 08/20/18 09:44:25 AM
#18246   Recruitment began in Jan, we are told namtae 08/20/18 08:18:08 AM
#18244   The massive dilution coming up is frightening. namtae 08/19/18 09:23:12 AM
#18243   LOL, laraz… reaper247 08/19/18 02:55:12 AM
#18240   LOL, namtae…nonsense. reaper247 08/19/18 12:19:17 AM
#18239   HERE IS M.D. ANDERSON'S PRE-CLINICAL_TRIAL_INFO_ON_PROLANTA/G129R>>>[ Rat Fink 08/18/18 05:13:01 PM
#18238   NEW GREAT BIOPHARMA ONCOLIX "ONCX"_CEO_INTERVIEW!!!_https:/ Rat Fink 08/18/18 05:12:26 PM
#18237   What are you talking about? You act like steadyhand 08/18/18 01:15:53 PM
#18236   Things are looking good here. Looking forward to steadyhand 08/18/18 01:13:51 PM
#18233  Restored Next round of funding, which they will desperately namtae 08/18/18 10:03:59 AM
#18232   Which R/S the first or the second one? laraz5 08/18/18 09:35:14 AM
#18231   ONCX planning a R/S? chaostrader 08/18/18 08:35:25 AM
#18230  Restored What's the ratio being used for Oncolix's Reverse Split? namtae 08/18/18 04:18:59 AM
#18229   WOW Oncolix is very busy registering shares for sale namtae 08/17/18 08:03:15 AM
#18227   NICE "ONCX" 44% GAIN!!! Rat Fink 08/17/18 12:14:17 AM
#18226   LOL, namtae…nonsense. reaper247 08/16/18 11:02:50 PM
#18225   Whats the over/under on how many days before namtae 08/16/18 01:08:46 PM
#18224   HERE IS M.D. ANDERSON'S PRE-CLINICAL_TRIAL_INFO_ON_PROLANTA/G129R>>>[ Rat Fink 08/16/18 10:07:44 AM
#18223   NEW GREAT BIOPHARMA ONCOLIX "ONCX"_CEO_INTERVIEW!!!_https:/ Rat Fink 08/16/18 10:07:10 AM
#18222   Whens the R/S? About 1 billion shares outstanding fully namtae 08/16/18 02:26:30 AM
#18220   I smell cake soak 08/15/18 06:00:48 PM
#18219   Starting to smell like a R/S looming namtae 08/15/18 03:39:51 PM
#18218   No one is gobbling up this POS on laraz5 08/15/18 03:25:17 PM
#18217   Lol soak 08/15/18 01:28:07 PM
#18216   Looking good. Patient buyers gobbling up all the namtae 08/15/18 01:27:18 PM
#18215   Awesome, I wonder which board members birthday it soak 08/15/18 01:06:28 PM
#18214   News soon... dont miss it namtae 08/15/18 09:06:48 AM
#18213   News soon, eh? LOL…maybe, maybe not. reaper247 08/15/18 12:28:32 AM
#18212   NICE "ONCX" 15% GAIN TODAY!!! Rat Fink 08/14/18 10:09:13 PM
#18211   News soon. If you know penny stocks, you namtae 08/14/18 09:22:53 AM
#18210   BIOPHARMA ONCX/ONCOLIX HAS "8" U.S. PATENTS_&_MANY_FOREIGN_PATENTS! Rat Fink 08/13/18 10:28:08 AM
#18209   Oncolix missing every Key Milestone in its path? laraz5 08/13/18 09:56:25 AM
#18207   NEW GREAT BIOPHARMA ONCOLIX "ONCX"_CEO_INTERVIEW!!!_https://www.youtube.com/ Rat Fink 08/12/18 10:26:32 PM
#18206   Still Zero Prolanta information coming from Oncolix? All deadlines laraz5 08/12/18 09:34:47 PM
#18205   7/17/18 ONCX FORMS SCIENTIFIC & CLINICAL_ADVISORY_BOARD_&_APPOINTS_1ST_MEM Rat Fink 08/12/18 08:56:50 PM
#18204   7/5/18 PR: "ONCX" EXPANDS MANAGEMENT TEAM_WITH_NEW_VP_OF_CORPORATE_DEVELOP Rat Fink 08/12/18 05:41:38 PM
#18203   Uh huh...this has already been covered. reaper247 08/12/18 02:31:09 AM
#18202   Oncolix owes 1.5 million for an expired contract laraz5 08/11/18 10:09:28 AM
#18201   Contract means...contract... “We incurred contract manufacturing costs of $9,92 BLight1911 08/10/18 04:15:27 PM
PostSubject